Insulet CorporationPODD
▼ NegativeRegulationrelevance
FDA classifies recall as Class I, the most serious type, due to potential insulin leakage causing serious injuries.
Impact on stocks 1
Biotech & Genomic Medicine
Insulet CorporationThe US FDA has classified a recall of certain Insulet Omnipod insulin pump systems as Class I, the most serious type. The recall affects specific lots of the Omnipod 5, Omnipod DASH, and Omnipod Eros devices. Insulet stated that pods in these lots may have a small tear in the cannula just above the skin, potentially causing insulin to leak and leading to under-delivery. As of May 20, Insulet reported 24 serious injuries and no deaths related to the issue.
Insulet CorporationFDA classifies recall as Class I, the most serious type, due to potential insulin leakage causing serious injuries.